Cargando…
Psychostimulants/Atomoxetine and Serious Cardiovascular Events in Children with ADHD or Autism Spectrum Disorder
BACKGROUND: Psychostimulants and atomoxetine have been shown to increase blood pressure, heart rate, and QT interval in children and adolescents; however, based on current literature, it is unclear if these “attention-deficit/hyperactivity disorder (ADHD) medications” are also associated with seriou...
Autores principales: | Houghton, Richard, de Vries, Frank, Loss, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982643/ https://www.ncbi.nlm.nih.gov/pubmed/31768949 http://dx.doi.org/10.1007/s40263-019-00686-4 |
Ejemplares similares
-
Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults
por: Schelleman, Hedi, et al.
Publicado: (2013) -
Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
por: Sumner, Calvin R, et al.
Publicado: (2009) -
Is there potential for the treatment of children with ADHD beyond psychostimulants?
por: Hoekstra, Pieter J.
Publicado: (2011) -
Risk of Tics with Psychostimulants for ADHD
por: Millichap, J. Gordon
Publicado: (2015) -
Psychostimulants Modafinil, Atomoxetine and Guanfacine Impair Bone Cell Differentiation and MSC Migration
por: Wagener, Nele, et al.
Publicado: (2022)